RESEARCH & DEVELOPMENT
The project’s research and development efforts focus on pioneering quantum technologies to push the limits of biomedical imaging and diagnostics. Key areas include developing quantum frequency combs and infrared lasers for highly sensitive spectroscopic imaging, allowing for in-depth molecular analysis at low light levels. Additionally, MUQUABIS explores hybrid sensors that combine optical and magnetic imaging to detect both electric and magnetic fields in biological samples simultaneously. These innovative tools are designed to open new avenues for understanding complex biological systems and to create a foundation for advanced diagnostic devices that could one day become standard in clinical settings.
We develop innovative quantum technologies to push the boundaries of biomedical imaging and diagnostics. Key tools include quantum frequency combs, infrared lasers, low-light spectroscopic imaging, and hybrid sensors, each enhancing our ability to study complex biological systems with unmatched precision.
QUANTUM FREQUENCY COMBS
Quantum frequency combs are advanced light sources that produce a spectrum of precise, evenly spaced frequencies, making them ideal for ultra-sensitive spectroscopic analysis. In MUQUABIS, these combs are developed to identify and study biological molecules with high precision, allowing researchers to monitor molecular interactions and structural changes at a new level of detail. This technology has the potential to enhance our understanding of complex biochemical processes that play critical roles in health and disease.
INFRARED LASERS
Infrared lasers are a powerful tool in biomedical research, as they penetrate biological tissues with minimal damage. MUQUABIS employs advanced infrared lasers for non-invasive imaging and spectroscopy, allowing researchers to investigate cellular structures and molecular compositions deeply within tissues. This capability is crucial for studying biological samples in their natural states and is expected to have a significant impact on diagnostic methods and therapeutic monitoring.
LOW-LIGHT SPECTROSCOPIC IMAGING
Low-light spectroscopic imaging is a technology that enables the study of biological molecules with minimal exposure to potentially harmful light. In MUQUABIS, this imaging technique is optimized to capture highly sensitive data on cellular proteins and metabolites, even in very faint light conditions. This approach is particularly valuable for examining delicate biological samples, such as living tissues, without interfering with their natural function.
HYBRID SENSORS
Hybrid sensors combine optical and magnetic sensing capabilities to simultaneously detect multiple types of biological signals. In MUQUABIS, these sensors integrate optical and magneto-microscopic techniques to observe both electric and magnetic fields in biological samples, such as cardiac cells. This dual-sensing approach provides comprehensive insights into the electrophysiological and biochemical activity of cells, offering a powerful tool for studying complex biological processes like cardiac arrhythmias and cellular signaling.
IMPACT
Benefits for Biomedical Research
Advanced quantum tools developed in MUQUABIS enable deeper, more precise exploration of biological systems, supporting breakthroughs in biomedical science.
Applications in Diagnosis and Treatment
The project’s technologies open new possibilities for non-invasive diagnostics and targeted treatments, advancing early detection and therapeutic options for various diseases.
Applications in Diagnosis and Treatment
By pioneering quantum applications in healthcare, MUQUABIS strengthens Europe’s leadership in quantum technology, aligning with strategic goals to drive innovation and competitiveness.